万维提示:
1、投稿方式:官网投稿
2、期刊网址:http://www.degruyter.com/view/j/labm
3、投稿网址:http://mc.manuscriptcentral.com/jlm
4、联系邮箱:JLM.editorial@deGruyter.com
5、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。
LaboratoriumsMedizin-Journal of Laboratory Medicine
Information for Authors
1. Scope and general policies of the Journal
2. Ethical conduct of research
3. Submission of manuscripts
4. Preparation of manuscripts
5. Post-acceptance
1. Scope and general policies of the Journal
LaboratoriumsMedizin (Journal of Laboratory Medicine; JLM) is a bi-monthly published journal that reports on the
latest developments in laboratory medicine. Particular focus is placed on the integrative diagnostic aspects of the
clinical laboratory, but technical, regulatory, and educational topics are equally covered. The Journal specializes in
the publication of high-standard, competent and timely review articles on clinical, methodological and pathogenic
aspects of modern laboratory diagnostics. These reviews are critically reviewed by expert reviewers and JLM’s
Associate Editors who are specialists in the various subdisciplines of laboratory medicine.
JLM is issued bi-monthly, and it is published in print and electronically. The preferred publication langauge is
English, articles in German language are translated into English and published online only.
JLM offers the following article formats:
Review and Mini Review – Systematic, narrative, and focused reviews. Review articles are normally
published by invitation, but suggestions to the Editors are welcome.
Research Article – Reports of original research.
Opinion Paper and Editorial
Point/Counterpoint Paper
Clinical Case Study-Mini Review
Clinical Case Report
Short Communication
Letter to the Editor and Reply
Guidelines and Recommendations
Book Review
Submissions in the following fields are welcomed:
Allergy and Autoimmunity
Biobanking
Clinical Chemistry and Metabolism
Drug Monitoring and Toxicology
Endocrinology
Genetics
Geriatric Laboratory
Haematology
Haemostasisiology
Inflammation and Sepsis
Laboratory Management
Microbiology
Neurological Laboratory
Oncology
Paediatric Laboratory
POCT
Transplantation- und Transfusion Medicine
Virology
Peer review JLM is a single-blind journal. Manuscripts are reviewed anonymously by at least two independent
reviewers selected by the Editors.
Turnaround times JLM aspires to notify authors about the review decision within 3-4 weeks from submission date.
Revised manuscripts should be returned within 6 weeks. Accepted articles are published online within 4 weeks
after acceptance.
Rejection of manuscripts Manuscripts dealing with subjects that have been well studied in the literature, and that
do not resolve questions raised by previous studies, or manuscripts that are statistically underpowered, are likely to
be rejected without peer re-view. This applies in particular to studies of genetic associations, which will be
considered only if they contribute new insights and are statistically valid according to generally accepted criteria.
Articles which are likely to affect the choice, performance or interpretation of clinical tests will be favored over
those which do not, and animal or cell-culture studies need to justify their eligibility. Reporting of negative results
must be justified by prior evidence that a positive result would be expected. Manuscripts are also returned to
authors if they do not comply with the Information for Authors (e.g., if the number of words al-lowed for a certain
article type will be exceeded).
Unpublished material Submission of a manuscript to JLM implies that the work described has not been published
previously, except in the form of an abstract, academic thesis or lecture; that it is not under consideration for
publication elsewhere; that publication of the work is approved by all authors and tacitly or explicitly by the
responsible authorities where the work was carried out; and that, if accepted, it will not be published elsewhere, in
English, German, or in any other language, without the written consent of the Publisher.
2. Ethical conduct of research
For information on plagiarism, please refer to COPE Committee on Publication Ethics. Please note that JLM uses
the check program iThenticate to assess for potential overlap in prior publication(s). Any previously published
material must be referenced appropriately in the manuscript.
Informed consent The protection of privacy is a legal right that must not be infringed without individual informed
consent. In cases where the identification of personal information is necessary for scientific reasons, authors should
obtain full documentation of informed consent, including written permission from the patient or their legal
guardians prior to inclusion in the study. The following (or similar) statement should be included in the Materials
and methods section: Informed consent was obtained from all individuals included in this study.
Authorization for the use of human subjects Manuscripts containing information related to human use should
clearly state that the research complies with all relevant national regulations and institutional policies and has been
approved by the authors Institutional Review Board or any equivalent Committee. Copies of the guidelines and
policy statements must be available for review by the Managing Editor if necessary. The editors reserve the right to
seek additional information or guidance from reviewers on any cases in which concerns arise. All investigations
with human subjects must have been conducted by following the tenets of the Declaration of Helsinki, what is
more authors must identify the committee or review board approving the experiments, and provide a statement
indicating approval of the research. The following (or similar) statement should be included in the Methods section:
Ethical approval: The research related to human use has been complied with all the relevant national regulations,
institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the
authors institutional review board or equivalent committee.
Authorization for the use of experimental animals Manuscripts containing information related to animals use
should clearly state that the research has complied with all relevant national regulations and institutional policies
and has been approved by the authors institutional review board or equivalent committee. Copies of the
guidelines and policy statements must be available for review by the Managing Editor if necessary. The editors
reserve the right to seek additional information or guidance from reviewers on any cases in which concerns arise.
The research using animal subjects should be conducted according to the Principles of Laboratory Animal Care and
similar documents (e.g. NIH). For manuscripts reporting experiments on live vertebrates or higher invertebrates,
authors must identify the committee approving the experiments, and must confirm that all experiments were
performed in accordance with relevant regulations. The following (or similar) statement should be included in
the Methods section: Ethical approval: The research related to animals use has been complied with all the
relevant national regulations and institutional policies for the care and use of animals.
If the manuscript does not contain any study that requires human or animal ethical approval, the following
statement should be included in the Methods section: Ethical approval: The conducted research is not related to
either human or animals use.
Conflict of interest and author contributions A conflict of interest for a given manuscript exists when a participant
in the peer review and publication process – author, reviewer, and editor – has ties to activities that could
inappropriately influence his or her judgment, regardless of whether judgment is, in fact, affected. Financial
relationships with industry (for example, employment, consultancies, stock ownership, honoraria, expert
testimony), either directly or through immediate family, are usually considered the most important conflicts of
interest. However, conflicts can occur for other reasons, such as financial support of the study, ties
to health insurance, politics or other stakeholders, personal relationships, academic competition, and intellectual
passion.
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest
(financial, personal or professional) in connection with the manuscript under evaluation. This must be declared
during the submission process and also at the end of the the manuscript. If you have no declaration to make,
please insert None declared. The below mentioned statement should be included before the Reference section (or
after the Acknowledgments section, if applicable). Authors must also declare responsibility for the entire content of
the manuscript and may declare individual contributions of each author, if applicable.
Acknowledgments: (If applicable).
Author contributions: All the authors have accepted responsibility for the entire content of this submitted
manuscript and approved submission.
Research funding: Declaration or None declared.
Employment or leadership: Declaration or None declared.
Honorarium: Declaration or None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and
interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Copyright Manuscripts are accepted on condition of transfer of copyright (for U.S. government employees: to the
extent transferable) to the publisher. Once the manuscript has been accepted, it may not be published elsewhere
without the consent of the copyright holders.
Note for authors of NIH-funded research De Gruyter acknowledges that the author of a US-agency-funded article
retains the right to provide a copy of the final manuscript to agency upon acceptance for publication or thereafter,
for public archiving in PubMed Central 12 months after publication in JLM. Note that only the accepted author’s
version of the manuscript, not the PDF file of the published article, may be used for NIH archiving.
3. Submission of manuscripts
Please submit manuscripts exclusively online at:
https://mc.manuscriptcentral.com/jlm
4. Preparation of manuscripts
Language Manuscripts should be written in clear and concise English (German). Please have your text proofread by
a native speaker or prefessional language service before you submit it for consideration. At proof stage, only minor
changes other than corrections of printers’ errors are allowed.
Cover letter Each manuscript should be accompanied by a cover letter containing a brief statement by the authors
describing the novelty and importance of their research.
General format and length Type the manuscript (including table legends, figure legends and references) doublespaced
using 12 pt font size and 1 inch margins. Number all pages. Do not use footnotes in the text, use
parentheses instead.
When you submit your work, please ensure the following:
The manuscript is complete and uploaded correctly. (The HTML version and the PDF file generated from
the submitted files must be approved.)
The title page contains the full title, short title, the full names of all authors (personal name, middle
initials, family name), and the full address and the academic title of the corresponding author. The title
page should also report the word count, the number of tables and figures, and whether the submission
includes any supplemental material.
All Figures and Tables have been uploaded and appear correctly at the end of the PDF.
Abstract, Keywords, List of Abbreviations, Tables and Figures, and captions and legends are included.
A Brief Summary consisting of no more than up to 3 sentences and up to 60 words is included. This
Summary will be published in the Table of Contents as initial introduction to the article.
Manuscript is spell-checked and within the word limit for the type of article.
References are in the correct format (Vancouver style) and cited sequentially in the text.
References mentioned in the reference list are cited in the text and vice versa.
Ethical approval is obtained and mentioned in the text.
Numbers in the text, tables, or figures use decimal points, not commas.
Supplier names, incl. city and country, are provided for reagents and apparatus reported in the
manuscript.
General format and length of the types of articles accepted for submission
Article Category Word count Word count in
abstracta
Number of
keywords
Number of Tables
Figures
Number of
references
Review Article 6000 200, unstructered
or structuredb
3-6 8 150
Mini Review 3500 200, unstructered
or structuredb
3-6 4 40
Research Article 3500 250, structuredc
3-6 8 50
Opinion Paper 3500 250, unstructered
or structuredb
3-6 2 40
Point
Counterpoint
1500 200, unstructured 3-5 2 15
Clinical Case StudyMini
Review
3500 200, unstructered
or structuredd
3-5 4 40
Case Report 1500 Unstructured 3-5 4 15
Short
Communication
1500 200, structureda
3-5 4 15
Letter to the Editor
Reply
1200 n/a 3-5 2 10
Guidelines and
Recommendations
3500 250, unstructured 3-6 6 40
Editorial 1500 n/a n/a 1 10
a
Plus Brief Summary of up to 3 sentences/up to 60 words .
b
Background, Content, Summary and Outlook. c
Background,
Methods, Results, Conclusions. d
Background, Case, Summary and Outlook.
Studies dealing with diagnostic accuracy: Please refer to the 2015 Standards for Reporting of Diagnostic Accuracy
checklist (STARD).
Systematic Reviews and Meta-Analyses of randomized controlled trials: Please refer to the Preferred Reporting
Items for Systematic Reviews and Meta- Analyses statement (PRISMA). Authors must include a suitable PRISMA
flow chart in their submission. The flow diagram depicts the flow of information through the different phases of a
systematic review. A template of the PRISMA flow diagram is available here as a PDF and Word document.
References Adhere strictly to the reference style of the Journal (Vancouver; recommendations of the “International
Committee of Medical Journals Editors see Reference Style). All references mentioned in the Reference list must
be mentioned in the text, and vice versa. List and number the references consecutively in the order that they
appear in the text, including Tables and Figures. In the text, identify references by Arabic numerals in
[parentheses]. Italic and boldface font type in the Reference section is not allowed. List all authors; if the number is
7 or more, list the first 6 names followed by et al. Identify authors by last name first, followed by up to 2 initials,
without periods, indicating the authors’ first name. Only the first name of the title is capitalized, as well as proper
names within the title. Journal names are abbreviated as indicated in PubMed and in the Web of Knowledge
(NIH.Linkout.Journals; Web of Knowledge), without periods. After the abbreviated journal name, give the year of
publication, followed by a semicolon, volume number (but no issue number), followed by a double colon, and the
page numbers, with the last page number in shortened format. Meeting abstracts may be cited only if published in
journals. Unpublished observations and personal communications are cited only in the text. Correct linking of the
references depends on strict adherence to Journal style.
Articles in journals: Haeckel R, Gurr E, Keller T. Permissible measurement uncertainty in the lower part of
measurement intervals. J Lab Med 2016;40:271-6.
Articles in journals with 7 or more authors: Ma X, Luo Y, Wang J, Zhang L, Liang Y, Wu Y et al. Comparison
of student perception and performance between case-based learning and lecture-based learning in a
clinical laboratory immunology course. J Lab Med2016;40:283-9.
Editorial: Klein H-G, Holdenrieder S. The role of cell-free nucleic acid diagnostics in clinical chemistry and
pathology. [Editorial] J Lab Med 2016;40:291-2.1881-2.
Letter to the Editor: Weykamp C, Kuypers A, Bakkeren D, Franck P, Loon Dv, Gunnewiek JK, et al.
Creatinine, Jaffe, and glucose: another inconvenient truth [Letter]. Clin Chem Lab Med. 2015;53:e347-9.
Supplements: Ploder M, Schroecksnadel K, Spittler A, Neurauter G, Roth E, Fuchs D. Moderate
hyperhomocysteinema in trauma and sepsis indicates poor survival. Clin Chem Lab Med
2009;47:Suppl:S187.
Books and Monographs: Kahn CR, Weir GC, editors. Joslin’s diabetes mellitus, 13th ed. Philadelphia: Lea
and Febiger, 1994:1068.
Chapters in Books: Karnofsky DH, Burchenal JH. The clinical evaluation of chemotherapeutic agents in
cancer. In: Macleod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University
Press, 1949:191–205.
Website: World Health Organization. WHO information for laboratory diagnosis of pandemic (H1N1) 2009
virus in humans update. Available at:
http://www.who.int/csr/resources/publications/swineflu/WHO_Diagnostic_RecommendationsH1N1_200
90521.pdf. Accessed: 6 Nov 2009.
Tables Number Tables consecutively using Arabic numerals. Provide a short descriptive title, column headings, and
(if necessary) footnotes to make each Table self-explanatory. In the footnote, refer to information within the Table
with superscript lowercase letters, and do not use special characters or numbers. Separate units with a comma and
use parentheses or square brackets for additional measures (e.g., %, range, etc). Refer to Tables in the text as Table
1, etc. Use Table 1 (boldface), etc. in the title of the Table.
Figures
General requirements: All illustrations must be of reproduction-ready quality. They will be reduced in size to fit,
whenever possible, the width of a single column. Lettering of all Figures within the article should be uniform in
style (preferably a sans serif typeface like Helvetica) and of sufficient size (ca. 10 pt.). Uppercase letters A, B, C, etc.
should be used to identify parts of multi-part Figures. In the legend, these letters are included in parentheses. Cite
all Figures in the text in numerical order. Indicate the approximate placement of each Figure. Do not embed Figures
within the text body of the manuscript.
Halftone figures and line drawings: Figures should have a minimum resolution of 300 dpi (halftone figures) and
1200 dpi (line drawings) and be of good contrast. Faint shading may be lost upon reproduction. When drawing bar
graphs, use patterning instead of grayscales.
Color plates: Authors are encouraged to submit illustrations in color if necessary for the scientific content of their
work. Publication of color Figures is provided free of charge both in online and print editions.
Figure legends: Provide a short descriptive title and a legend, either below the Figure, in the main text, or on
separate pages, to make each Figure self-explanatory. Explain all symbols used in a Figure. Remember to use the
same abbreviations as in the text body.
Videos: Authors are encouraged to submit videos accompanying the article as Supplemental Material.
Supplemental material You may submit Supplemental material, i.e. additional tables, figures, videos, appendices or
other additional material (e.g. references) that exceeds the limitation of the article and/or illustrates the contents
of your article. Supplemental material should be uploaded as separate file(s) during submission. Within the text,
Supplemental material must be cited consecutively and be referred to as Supplemental material (e.g. see
Supplemental Material, Figure 1, or Supplemental Figure 1). Supplemental material is subject to peer review as part
of the manuscript. If the manuscript is accepted and the Supplemental material is posted online, it will be
referenced in the article of the printed version together with the URL where it can be found.
Nomenclature Follow the rules of the IUPAC-IUB Commission on Biochemical Nomenclature, as indicated in IUB
Biochemical Nomenclature and Related Documents. Enzyme names should be in accordance with the
recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature, 1978, as in Enzyme
Nomenclature, published by Academic Press, New York, 1992. Genotypes should be given in italics, phenotypes
should not be italicized. Indicate the gene symbol and gene name as approved by the HUGO Gene Nomenclature
Committee. Nomenclature of bacterial genetics should follow Damerec et al. Genetics 1966; 54:61–76 (Damerec et
al.).
Permissions It is the authors’ responsibility to obtain permission to reproduce original or modified material that has
been previously published elsewhere.
5. For authors interested in Open Access publication
If your manuscript is accepted, open access publication is available for authors who wish to make their article freely
available on De Gruyter Online. Authors choosing to publish open access pay an article processing charge. All
articles undergo peer review and will be accepted for publication based on the quality of their scientific
contribution. Choosing open access publication has no influence on the peer review or acceptance process. For
more information on De Gruyter’s open access policies please visit:
http://www.degruyter.com/dg/page/577/open-access-policy
6. Post-acceptance
Proofs The corresponding author of an article will receive the proofs in electronic form to check for editing and
type-setting accuracy. Major changes to the article as accepted for publication will not be considered at this stage,
unless the authors pay for these changes.
Offprints The electronic files of typeset articles in Adobe Acrobat PDF format are provided free of charge;
corresponding authors receive an e-mail notification that their article has been published online. Paper offprints
can be ordered in addition; an offprint order form will accompany the page proofs and should be completed and
returned with the corrected proofs immediately if offprints are requested.
Please contact the Editorial Office with any further questions: Heike Jahnke, T: +49 30 26005-220, F: +49 30
26005-325, E-mail: JLM.editorial@deGruyter.com
本文链接: http://jlmchem.immuno-online.com/view-729828.html